These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35514199)

  • 1. Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports.
    Garcia-Azorin D; Baykan B; Beghi E; Doheim MF; Fernandez-de-Las-Penas C; Gezegen H; Guekht A; Hoo FK; Santacatterina M; Sejvar J; Tamborska AA; Thakur KT; Westenberg E; Winkler AS; Frontera JA;
    Cephalalgia; 2022 Oct; 42(11-12):1207-1217. PubMed ID: 35514199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis.
    García-Azorín D; Do TP; Gantenbein AR; Hansen JM; Souza MNP; Obermann M; Pohl H; Schankin CJ; Schytz HW; Sinclair A; Schoonman GG; Kristoffersen ES
    J Headache Pain; 2021 Sep; 22(1):108. PubMed ID: 34535076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    Kan Y; Asada M; Uesawa Y
    PLoS One; 2022; 17(8):e0269268. PubMed ID: 35913955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.
    Dag Berild J; Bergstad Larsen V; Myrup Thiesson E; Lehtonen T; Grøsland M; Helgeland J; Wolhlfahrt J; Vinsløv Hansen J; Palmu AA; Hviid A
    JAMA Netw Open; 2022 Jun; 5(6):e2217375. PubMed ID: 35699955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis.
    Santi Laurini G; Montanaro N; Motola D
    Eur J Clin Pharmacol; 2023 May; 79(5):657-661. PubMed ID: 36961579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Woo EJ; Mba-Jonas A; Thomas A; Baer B; Day B; Kim Y; Gomez-Lorenzo M; Nair N
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1174-1181. PubMed ID: 36065046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
    JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
    Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.
    Gee J; Marquez P; Su J; Calvert GM; Liu R; Myers T; Nair N; Martin S; Clark T; Markowitz L; Lindsey N; Zhang B; Licata C; Jazwa A; Sotir M; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):283-288. PubMed ID: 33630816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
    Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache.
    Martelletti P
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism after COVID-19 Vaccination: A Systematic Review of Such Events in 286 Patients.
    Mani A; Ojha V
    Ann Vasc Surg; 2022 Aug; 84():12-20.e1. PubMed ID: 35568325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.
    Schulz JB; Berlit P; Diener HC; Gerloff C; Greinacher A; Klein C; Petzold GC; Piccininni M; Poli S; Röhrig R; Steinmetz H; Thiele T; Kurth T;
    Ann Neurol; 2021 Oct; 90(4):627-639. PubMed ID: 34288044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?
    Syed K; Chaudhary H; Donato A
    Am J Case Rep; 2021 Sep; 22():e933397. PubMed ID: 34478433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful management of intracranial hemorrhage in a patient with COVID-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous thrombosis.
    Shen CF; Lin MS; Shen CC; Yang MY
    Asian J Surg; 2022 Dec; 45(12):2838-2839. PubMed ID: 35753920
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports.
    Riad A; Põld A; Kateeb E; Attia S
    Front Public Health; 2022; 10():952781. PubMed ID: 35899169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of neurological side effects of COVID-19 vaccination.
    Hosseini R; Askari N
    Eur J Med Res; 2023 Feb; 28(1):102. PubMed ID: 36841774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.